glp 1 induced pancreatitis GLP-1 Agonists and Risk GLP-1 RAs: Safe, Effective, Possibly

45:2118-2126 [PMC free article: PMC9472498] [PubMed: 35817022] 249

This combination is different from semaglutide and tirzepatide

What they're saying: "The sheer cost of these medications is a huge barrier to access," Dr

What the Research Says About GLP-1s and HS While clinical research is still in early stages, several studies support what many of us in the HS community have seen anecdotally: A 2024 study of patients with HS found that semaglutide reduced the frequency of flares and systemic inflammationflaring decreased from once every 8.5 weeks to once every 12 weeks

13 Continued use of GLP-1 for almost another year resulted in 8% further loss of body weight while changing to a placebo resulted in gaining most of the weight back

AHA Journals+1 A new twist: statins, the microbiome, bile acids and lower GLP-1 In 2024, a high-quality translational study reported that statins can aggravate insulin resistance by reducing circulating active GLP-1 levels and that the effect appears to be microbiome-dependent